Ovulation Disorder
18
2
2
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
39%
7 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (18)
LE + CC vs. LE for Ovulation Induction
Prevalence of Hyperandrogenism in Type 1 Diabetes
Clinical Trial of Anovulatory Infertility
Clusterin Level and Polycystic Ovary Syndrome
Three Dimensional Ultrasonographic Detection of Human Ovulation
Ovulation Double Check (Proov) Verification and Usability Testing
Inhibin B/AFC Ratio for Ovarian Response
Feasibility and Safety of Fasting in Fertility Treatment
Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?
The Role of Estrogen in Luteinizing Hormone Surge and Ovulation
Serial Progesterone Level Measurements During the Menstrual Cycle in Subfertile Women
Incremental Clomiphene Citrate Doses in Successive Cycles and FSH, LH and Steroid Hormone Levels
Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS)
Usability Study of the Pearl Fertility Tracking Device
Pulsatile Gonadotropin-releasing Hormone for Infertility in Non-obese Patients With Polycystic Ovary Syndrome
"Stair Step Study"
Human Chorionic Gonadotrophin & Trigger
Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response